109793-66-0 Usage
Description
(E)-N-(1-phenylethylideneamino)piperidine, also known as (E)-N-[(1-phenylethylidene)amino]piperidine, is a chemical compound with the molecular formula C18H24N2. It is a derivative of piperidine featuring a phenylethylidene substituent, which is commonly utilized in research and experimental studies. (E)-N-(1-phenylethylideneamino)piperidine has been investigated for its potential pharmacological and biological activities, such as serving as a receptor ligand or a component in the pharmaceutical industry. The specific properties and applications of (E)-N-(1-phenylethylideneamino)piperidine can vary based on the context and objectives of the research it is involved in.
Uses
Used in Pharmaceutical Research:
(E)-N-(1-phenylethylideneamino)piperidine is used as a research compound for exploring its potential as a receptor ligand. Its unique structure allows it to interact with specific biological targets, which can be beneficial in the development of new drugs and therapies.
Used in Chemical Synthesis:
In the field of chemical synthesis, (E)-N-(1-phenylethylideneamino)piperidine is used as a building block or intermediate for the creation of more complex molecules. Its versatile structure can be further modified to produce a variety of compounds with different properties and applications.
Used in Medicinal Chemistry:
(E)-N-(1-phenylethylideneamino)piperidine is employed as a key component in medicinal chemistry, where it is studied for its potential to treat various diseases and conditions. Its interaction with biological receptors can provide insights into the development of novel therapeutic agents.
Used in Drug Design:
In the drug design industry, (E)-N-(1-phenylethylideneamino)piperidine is used as a template for designing new pharmaceuticals. Its structural features can be optimized to enhance its binding affinity, selectivity, and overall efficacy as a drug candidate.
Used in Neuropharmacology:
(E)-N-(1-phenylethylideneamino)piperidine is utilized in neuropharmacology as a tool to study the function and modulation of various neurotransmitter receptors. This can lead to a better understanding of neurological disorders and the development of targeted treatments.
Used in Analytical Chemistry:
As an analytical chemistry standard, (E)-N-(1-phenylethylideneamino)piperidine is used to validate and calibrate analytical instruments, ensuring accurate measurements and data interpretation in various chemical analyses.
Check Digit Verification of cas no
The CAS Registry Mumber 109793-66-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,9,7,9 and 3 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 109793-66:
(8*1)+(7*0)+(6*9)+(5*7)+(4*9)+(3*3)+(2*6)+(1*6)=160
160 % 10 = 0
So 109793-66-0 is a valid CAS Registry Number.
109793-66-0Relevant articles and documents
Rh(I) and Ir(I) catalysed intermolecular hydroamination with substituted hydrazines
Dabb, Serin L.,Messerle, Barbara A.
, p. 6368 - 6371 (2008)
The catalysed intermolecular hydroamination of a series of terminal alkynes with substituted hydrazines was achieved using Rh(i) and Ir(i) complexes.
Inhibiteurs mixtes des voies de la cyclooxygenase et des lipoxygenases: synthese et activite de derives hydrazoniques
Ghiglieri-Bertez, Chantal,Coquelet, Claude,Alazet, Alain,Bonne, Claude
, p. 147 - 152 (2007/10/02)
Dual inhibitors of the cyclooxygenase and lipoxygenase pathways: synthesis and activity of hydrazone derivatives.Non-steroidal anti-inflammatory drugs (NSAIDs) act by preventing prostaglandin production.In recent years, research on non-steroid dual inhibitors of prostaglandin and leukotriene biosyntheses has been developed.These compounds should represent a new class of anti-inflammatory drugs, with a wider spectrum of activity than classical NSAIDs.The present paper reports the synthesis of hydrazone derivatives.The effect of various substitutions is studied on platelet cyclooxygenase (i.e. prostaglandin synthesis) and on leukocyte 5-lipoxygenase (i.e. leukotriene synthesis).Among the 50 tested compounds, 2 hydrazone derivatives were selected for their significant dual inhibitory potency: 2-acetylthiophene-2-thiazolylhydrazone 5g, and N-phenyl benzimidrazone 6c.Keywords - non-steroidal anti-inflammatory drugs / hydrazones / dual inhibitor / cyclooxygenase / lipoxygenase
